FIELD: medicine.
SUBSTANCE: invention relates to an andrographolide enteric targeting micropellet and a method for its preparation; furthermore, the present invention also relates to uses of andrographolide enteric targeting micropellets in the preparation of a pharmaceutical for treatment of inflammatory bowel disease.
EFFECT: use of andrographolide in the preparation of a pharmaceutical preparation for the treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet and the method for its preparation are disclosed.
28 cl, 8 dwg, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT | 2004 |
|
RU2372893C2 |
THE PHARMACEUTICAL COMPOSITIONS CONTAINING pH - DEPENDENT MEDICAL PRODUCT, THE pH MODIFIER AND THE SLOWING DOWN AGENT | 2006 |
|
RU2442574C2 |
PHARMACEUTICAL COMPOSITION COVERED BY ENTEROSOLUBLE ENVELOPE AND METHOD OF ITS PREPARING | 1998 |
|
RU2197227C2 |
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS UNSTABLE IN MEDICINAL ACID MEDIUM | 2006 |
|
RU2440101C2 |
TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING | 1998 |
|
RU2201217C2 |
MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
SOLID PHARMACEUTICAL PREPARATION OF MATRIX TYPE | 2012 |
|
RU2600797C2 |
SOLID PHARMACEUTICAL PREPARATION OF MATRIX TYPE | 2008 |
|
RU2465916C2 |
DOSAGE FORMS OF RISEDRONATE | 2005 |
|
RU2381791C2 |
PHARMACEUTICAL FORM FOR DRUG DELIVERY TO THE COLON | 2007 |
|
RU2646825C2 |
Authors
Dates
2019-03-14—Published
2014-08-06—Filed